Rivastigmine RIVASTIGMINE ZYDUS LIFESCIENCES LIMITED FDA Approved No description available yet.

Drug Facts

Composition & Profile

Identifiers & Packaging

Container Type UNKNOWN
UNII
PKI06M3IW0
Packaging

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Rx only NDC 70771-1949-7 Rivastigmine Transdermal System Each System Delivers 4.6 mg/24 hours For Transdermal Use Only. Contains 30 systems Rx only NDC 70771-1950-7 Rivastigmine Transdermal System Each System Delivers 9.5 mg/24 hours For Transdermal Use Only. Contains 30 systems Rx only NDC 70771-1951-7 Rivastigmine Transdermal System Each System Delivers 13.3 mg/24 hours For Transdermal Use Only. Contains 30 systems 4.6 mg/24 hrs 9.5 mg/24 hrs 13.3 mg/24 hrs

Package Descriptions
  • PACKAGE LABEL.PRINCIPAL DISPLAY PANEL Rx only NDC 70771-1949-7 Rivastigmine Transdermal System Each System Delivers 4.6 mg/24 hours For Transdermal Use Only. Contains 30 systems Rx only NDC 70771-1950-7 Rivastigmine Transdermal System Each System Delivers 9.5 mg/24 hours For Transdermal Use Only. Contains 30 systems Rx only NDC 70771-1951-7 Rivastigmine Transdermal System Each System Delivers 13.3 mg/24 hours For Transdermal Use Only. Contains 30 systems 4.6 mg/24 hrs 9.5 mg/24 hrs 13.3 mg/24 hrs